Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | FABP4 | P15090 | 9/20 | 0.44 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4880115 | 0.79 | LDHA (0.62) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL1339739 | 0.79 | ALDH1A1 (0.53) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL3174180 | 0.79 | ALDH1A1 (0.53) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL4573139 | 0.79 | ALDH1A1 (0.53) | ALDH1A1TSHRGAAHTTNPSR1 | |
| Hydrochloric Acid SCHEMBL27989876 | 0.78 | ALDH1A1 (0.51) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL28550814 | 0.78 | ALDH1A1 (0.51) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL6548757 | 0.76 | ALDH1A1 (0.54) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL19922628 | 0.75 | TTR (0.50) | ALDH1A1TSHRGAALDHA | |
| SCHEMBL2371975 | 0.75 | GAA (0.56) | ALDH1A1TSHRGAAHTTNPSR1 | |
| SCHEMBL15352744 | 0.75 | ALDH1A1 (0.49) | ALDH1A1TSHRGAAHTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222330-A1 | New Compounds | BIOVITRUM AB (SE) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222330-A1 | New Compounds | SULT2A1, GPR119, STS | ALDH1A1 363/4885TSHR 1178/4885GAA 424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.